FDA Discovers Second Impurity in Chinese Manufacturer’s Valsartan By Sam | September 13, 2018 Another impurity has been detected in Zhejiang Huahai Pharmaceuticals’ ill-fated active ingredient valsartan, the FDA announced Thursday. Source: Drug Industry Daily Posted in Drug Industry Daily